3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 23497317 | Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms. | 2013 Mar 7 | 4 |
| 2 | 23714533 | The role of kinase inhibitors in the treatment of patients with acute myeloid leukemia. | 2013 | 2 |
| 3 | 22504184 | Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia. | 2012 Apr 15 | 1 |